- Home
- SPCB vs KZR Comparison
SPCB vs KZR Comparison
Compare SPCB & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPCB | KZR |
|---|---|---|
| Founded | 1988 | 2015 |
| Country | Israel | United States |
| Employees | N/A | 55 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.3M | 51.3M |
| IPO Year | 2004 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SPCB | KZR |
|---|---|---|
| Price | $8.50 | $7.09 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 41.2K | ★ 55.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $27.13 | N/A |
| P/E Ratio | $10.36 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.10 | $3.53 |
| 52 Week High | $13.57 | $7.45 |
Technical Indicators
Market Signals| Indicator | SPCB | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 49.22 | 64.49 |
| Support Level | $8.51 | $6.06 |
| Resistance Level | $9.86 | N/A |
| Average True Range (ATR) | 0.39 | 0.24 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 46.36 | 62.37 |
Price Performance
Historical ComparisonAbout SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.